Page last updated: 2024-10-21

phenytoin and Glomerulosclerosis, Focal Segmental

phenytoin has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies

Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Phelps, SJ1
Baldree, LA1
Boucher, BA1
Hogue, SL1

Other Studies

1 other study available for phenytoin and Glomerulosclerosis, Focal Segmental

ArticleYear
Neuropsychiatric toxicity of phenytoin. Importance of monitoring phenytoin levels.
    Clinical pediatrics, 1993, Volume: 32, Issue:2

    Topics: Administration, Oral; Adolescent; Akathisia, Drug-Induced; Anemia, Sickle Cell; Cerebral Infarction;

1993